No Admissions. You understand and agree that the promises and payments in consideration of this Agreement shall not be construed to be an admission of any liability or obligation by the Company to you or to any other person, and that the Company makes no such admission.
Arcus Biosciences, Inc. (RCUS) (CIK 0001724521)
Source: SEC EDGAR database • Date: November 5, 2019 • SIC: 2834 • CIK: 2834
Eiger BioPharmaceuticals, Inc. (EIGR) (CIK 0001305253)
Source: SEC EDGAR database • Date: March 14, 2019 • SIC: 2836 • CIK: 2836
Arcus Biosciences, Inc. (RCUS) (CIK 0001724521)
Source: SEC EDGAR database • Date: March 5, 2019 • SIC: 2834 • CIK: 2834
Adverum Biotechnologies, Inc. (ADVM) (CIK 0001501756)
Source: SEC EDGAR database • Date: November 8, 2018 • SIC: 2836 • CIK: 2836
Mattersight Corp (MATR) (CIK 0001094348)
Source: SEC EDGAR database • Date: March 12, 2018 • SIC: 7373 • CIK: 7373
VICAL INC (BBI) (CIK 0000819050)
Source: SEC EDGAR database • Date: July 12, 2019 • SIC: 2836 • CIK: 2836
FIVE PRIME THERAPEUTICS, INC. (FPRX) (CIK 0001175505)
Source: SEC EDGAR database • Date: November 6, 2019 • SIC: 2834 • CIK: 2834
Aravive, Inc. (ARAV) (CIK 0001513818)
Source: SEC EDGAR database • Date: November 20, 2018 • SIC: 2834 • CIK: 2834